Poietis products

NGB-R is a multimodal and high-end, 4D bioprinting system developed and designed specifically for tissue engineers, researchers and biologists. Combining laser-assisted, micro-valve and extrusion bioprinting, it enables true versatility of bioprinting (from cell to spheroids) and offers the possibility of using a large number of biomaterials and hydrogels. NGB-R includes an embedded microscope for in-line cell printing monitoring and relies on a complete software suite for managing bioprinting protocols, from biological CAD to data analysis of manufacturing.

NGB-C is a clinical-grade, GMP-compliant Bioprinter designed to meet the needs of Advanced Therapy Medicinal Products (ATMP) production and the requirements of Poietis’ partners.

Poieskin is a Human Full Thickness Skin Model entirely produced by 3D bioprinting. Poieskin consists of a dermal compartment composed of primary human fibroblasts embedded in a collagen I matrix overlaid by a stratified epidermis derived from primary human keratinocytes.

Next Generation Bioprinting (NGB) plaform has been developed to overcome current tissue manufacturing methods which are the bottleneck impeding standardisation, scale-up and large-scale market adoption of Tissue-Engineering products. It solves critical limitations of existing 3D bioprinting technologies thanks to single-cell resolution and learning-based methods.

POIETIS leverages its experience and expertise in skin bioprinting to develop a first therapeutic product to treat chronic wound healing tissus such as diabetic foot ulcers or venous ulcers.